Evidence map›Paper›PMID 24090729›Full record

SynthesisClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2014

Evidence and recommendations for imaging liver fat in children, based on systematic review.

Hannah I Awai, Kimberly P Newton, Claude B Sirlin, Cynthia Behling, Jeffrey B Schwimmer

2 registry-linked trialsOpen access · greenAbstract readEvaluation StudySystematic Review
In one paragraph

Synthesis in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03783195 nacompletednot on this mapstarted 2019, after this paper: background citation

Genetic-specific Effects of Fructose on Liver Lipogenesis

TypeinterventionalSponsorUniversity of North Carolina, Chapel HillRan2019 to 2023Enrolled15ConditionsNAFLDArmsSugar drink
NCT04671186 nacompletednot on this mapstarted 2020, after this paper: background citation

Role of Probiotics in Treatment of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Patients by Assessing With Fibroscan

TypeinterventionalSponsorNorthwell HealthRan2020 to 2023Enrolled47ConditionsNon-Alcoholic Fatty Liver DiseaseArmsCulturelle (Lactobacillus rhamnosus strain GG), Placebo
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hannah I AwaiDivision of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California; Liver Imaging Group, Department of Radiology, University of California, San Diego School of Medicine, San Diego, California.
Kimberly P NewtonDivision of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California.
Claude B SirlinLiver Imaging Group, Department of Radiology, University of California, San Diego School of Medicine, San Diego, California.
Cynthia BehlingDepartment of Pathology, Sharp Medical Center, San Diego, California.
Jeffrey B SchwimmerDivision of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, San Diego, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California; Liver Imaging Group, Department of Radiology, University of California, San Diego School of Medicine, San Diego, California. Electronic address: jschwimmer@ucsd.edu.
Rady Children's Hospital-San Diego · USUniversity of California, San Diego · USSharp Memorial Hospital · US

Funding

Technical Validation of MRI Biomarkers of Liver FatR01DK088925 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI REEDER, SCOTT B., SIRLIN, CLAUDE B · 2010 to 2021
$7.1M
Development of MR Based Biomarker Panels for NAFLD _ A NASH CRN Ancillary StudyR56DK090350 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SCHWIMMER, JEFFREY BARNETT, SIRLIN, CLAUDE B · 2010 to 2012
$2.2M
NIDDK NIH HHS DK088925-02S1NIDDK NIH HHS R01 DK088925NIDDK NIH HHS R56 DK090350NIDDK NIH HHS R56-DK090350-01A1
6 · The paper itself

Abstract

BACKGROUND &

aimsFatty liver is a common problem in children and increases their risk for cirrhosis, diabetes, and cardiovascular disease. Liver biopsy is the clinical standard for diagnosing and grading fatty liver. However, noninvasive imaging modalities are needed to assess liver fat in children. We performed a systematic review of studies that evaluated imaging liver fat in children.

methodsWe searched PubMed for original research articles in peer-reviewed journals from January 1, 1982, through December 31, 2012, using the key words "imaging liver fat." Studies included those in English, and those performed in children from birth to 18 years of age. To be eligible for inclusion, studies were required to measure hepatic steatosis via an imaging modality and a quantitative comparator as the reference standard.

resultsWe analyzed 9 studies comprising 610 children; 4 studies assessed ultrasonography and 5 studies assessed magnetic resonance imaging (MRI). Ultrasonography was used in the diagnosis of fatty liver with positive predictive values of 47% to 62%. There was not a consistent relationship between ultrasound steatosis score and the reference measurement of hepatic steatosis. Liver fat as measurements by MRI or by spectroscopy varied with the methodologies used. Liver fat measurements by MRI correlated with results from histologic analyses, but sample size did not allow for an assessment of diagnostic accuracy.

conclusionsAvailable evidence does not support the use of ultrasonography for the diagnosis or grading of fatty liver in children. Although MRI is a promising approach, the data are insufficient to make evidence-based recommendations regarding its use in children for the assessment of hepatic steatosis.

Indexed as

Magnetic Resonance ImagingAdolescentChildChild, PreschoolFatty LiverHumansImage Processing, Computer-AssistedInfantInfant, NewbornLiverRadiographyUltrasonographyEvidence-Based MedicineLiver ImagingNAFLD

Identifiers

PMID24090729
PMCPMC3969892
OpenAlexW2015631930

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.